ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Georgia » Clinical Cardiac Electrophysiology

Top Clinical Cardiac Electrophysiology Prescribers in Georgia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
FELIX SOGADE M.D.

Clinical Cardiac Electrophysiology

5,799

$362K

723
542 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 23%

$62
Average prescription price

Avg: $64

JOSEPH POKU M.D.

Clinical Cardiac Electrophysiology

3,441

$266K

469
338 are 65+

15%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 23%

$77
Average prescription price

Avg: $64

DAVID WOODARD M.D.

Clinical Cardiac Electrophysiology

3,064

$138K

334
289 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

23%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 23%

$45
Average prescription price

Avg: $64

STEPHEN PRATER MD

Clinical Cardiac Electrophysiology

2,677

$181K

360
307 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 23%

$68
Average prescription price

Avg: $64

BRYAN PIEDAD M.D.

Clinical Cardiac Electrophysiology

2,588

$156K

301
265 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 23%

$60
Average prescription price

Avg: $64

AMIT SHAH M.D.

Clinical Cardiac Electrophysiology

2,564

$79.6K

279
217 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 23%

$31
Average prescription price

Avg: $64

DAVID CLARK MD

Clinical Cardiac Electrophysiology

2,458

$147K

241
206 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 23%

$60
Average prescription price

Avg: $64

JONATHAN LANGBERG MD

Clinical Cardiac Electrophysiology

2,222

$217K

239
205 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 23%

$98
Average prescription price

Avg: $64

KAMIL HANNA MD

Clinical Cardiac Electrophysiology

2,175

$82.4K

275
212 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 23%

$38
Average prescription price

Avg: $64

MARK JENKINS M.D.

Clinical Cardiac Electrophysiology

2,026

$137K

239
195 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 23%

$67
Average prescription price

Avg: $64

MICHAEL CHISNER M.D.

Clinical Cardiac Electrophysiology

1,995

$91.5K

254
213 are 65+

21%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 23%

$46
Average prescription price

Avg: $64

JOON AHN MD

Clinical Cardiac Electrophysiology

1,860

$135K

275
238 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 23%

$73
Average prescription price

Avg: $64

THOMAS DEERING MD

Clinical Cardiac Electrophysiology

1,819

$135K

304
264 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 23%

$74
Average prescription price

Avg: $64

MOHAMMAD KOOSHKABADI MD

Clinical Cardiac Electrophysiology

1,809

$115K

206
183 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 23%

$63
Average prescription price

Avg: $64

ANSHUL PATEL MD

Clinical Cardiac Electrophysiology

1,507

$117K

213
202 are 65+

14%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 23%

$77
Average prescription price

Avg: $64

NARENDRA KANURU M.D.

Clinical Cardiac Electrophysiology

1,500

$95.3K

245
215 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 23%

$64
Average prescription price

Avg: $64

DAVID DELURGIO M.D.

Clinical Cardiac Electrophysiology

1,220

$118K

221
178 are 65+

12%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 23%

$97
Average prescription price

Avg: $64

JACOB BLATT M.D.

Clinical Cardiac Electrophysiology

1,218

$64.1K

218
187 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 23%

$53
Average prescription price

Avg: $64

CESAR EGOAVIL M.D.

Clinical Cardiac Electrophysiology

1,181

$76.1K

232
204 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 23%

$64
Average prescription price

Avg: $64

ANDREW WICKLIFFE MD

Clinical Cardiac Electrophysiology

1,133

$109K

199
175 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

10%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 23%

$97
Average prescription price

Avg: $64

MUHAMMED ALI MD

Clinical Cardiac Electrophysiology

1,129

$66.6K

190
171 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 23%

$59
Average prescription price

Avg: $64

DAVID NABERT M.D.

Clinical Cardiac Electrophysiology

1,109

$36.5K

200
161 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 23%

$33
Average prescription price

Avg: $64

MICHAEL RILEY M.D.

Clinical Cardiac Electrophysiology

1,083

$67.5K

177
143 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 23%

$62
Average prescription price

Avg: $64

BRUCE STAMBLER MD

Clinical Cardiac Electrophysiology

1,025

$89.4K

121
107 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 23%

$87
Average prescription price

Avg: $64

BOBBY SMITH MD

Clinical Cardiac Electrophysiology

975

$68.8K

191
174 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

10%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 23%

$71
Average prescription price

Avg: $64

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank